Kilitch Drugs (India) share news, announcements and annual reports
NSE: KILITCHBSE: 524500Pharmaceuticals & BiotechnologySmall Cap
Kilitch Drugs (India) Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1994 on BSE, Sep 2010 on NSE
Last close ₹201.32down ₹7.82 (3.74%)BSE ₹201.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹209.14.
30 Oct: open ₹211.45, high ₹212.24, low ₹200.25
52-week range of traded prices to 30 Oct 2026
₹117.25Low, 30 Mar 2026₹267.90High, 7 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹704 Cr1,776th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 23.42
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.52
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 12.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.32
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 34,67341.3% delivered
Kilitch Drugs (India) shareholder meetings
56 filed, newest first. Page 1 of 2.
Oct 2026
Aug 2026
27 Aug · Meeting
Mar 2026
Feb 2026
Sep 2025
26 Sep · Meeting
Sep 2024
27 Sep · Meeting
27 Sep · Meeting
Sep 2023
29 Sep · Meeting
Apr 2023
Mar 2023
Sep 2022
30 Sep · Meeting
30 Sep · Meeting
5 Sep · Meeting
Jan 2022
Dec 2021
Sep 2021
29 Sep · Meeting
Oct 2020
Sep 2020
30 Sep · Meeting
Oct 2019
Sep 2019
30 Sep · Meeting
Aug 2019
Sep 2018
27 Sep · Meeting
Aug 2018
Oct 2017
Sep 2017
29 Sep · Meeting
Aug 2017
2 Aug · Meeting
Sep 2016
Aug 2016
Oct 2015
Aug 2015
Sep 2014
8 Sep · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from September 25, 2014 to September 30, 2014 (both days inclusive) for the purpose of Annual General Meeting of the Company scheduled to be held on September 30, 2014.
Oct 2013
Aug 2013
19 Aug · Meeting
Company has fixed Book Closure from September 26, 2013 to September 30, 2013 (both days inclusive) for the purpose of Annual General Meeting of the Company to be held on September 30, 2013.